Effect of AZD4017, a Selective 11β-HSD1 Inhibitor, on Bone Turnover Markers in Postmenopausal Osteopenia
Afroze Abbas, Paul M. Stewart(University of Leeds), Mark S. Cooper(The University of Sydney), Jamie B. Oughton, Rachel Crowley(St. Vincent's University Hospital), Richard Eastell(University of Sheffield), Sarah Brown(University of Leeds), Rebecca J. Fairclough(AstraZeneca (United Kingdom)), Gemma Ainsworth(University of Leeds), Marian Schini(University of Sheffield)
Cited by 11
Related Papers
Denosumab for Prevention of Fractures in Postmenopausal Women with Osteoporosis
|New England Journal of Medicine|2009|3.5k
Treatment of Acromegaly with the Growth Hormone–Receptor Antagonist Pegvisomant
|New England Journal of Medicine|2000|874
Efficacy and safety of balloon kyphoplasty compared with non-surgical care for vertebral compression fracture (FREE): a randomised controlled trial
|The Lancet|2009|837